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In The Lancet Infectious Diseases,1 Simon Brooker and 
colleagues invite us to think more expansively about what 
is possible in addressing soil-transmitted helminthiasis 
(STH). STH is increasingly recognised as a neglected 
tropical disease with serious consequences for the health, 
nutrition, education, and economic development of 
aﬀ ected populations.2 It has been 14 years since the 
World Health Assembly (WHA) approved resolution 
WHA54.19—a nuanced call for elimination of STH as a 
public health problem in areas of low transmission and 
for reducing morbidity in areas of high transmission.3 
Since then, eﬀ orts have been directed primarily toward 
reducing STH-related morbidity in a single, although 
important, risk group, school-age children. We have 
relied overwhelmingly on one intervention—periodic 
mass treatment with deworming drugs (preventive 
chemotherapy)—and drug coverage as a single measure 
of success. This highly focused approach amounts to a 
selective reading, or at least a part implementation, of 
WHA54.19, which also promoted improved access to 
water, sanitation, and hygiene (WASH) and preventive 
chemotherapy for women and young children. 
In the words of the poet Charles Bukowski, a “fresh wild 
wind” has begun to energise the STH community with 
improved alignment with WHA’s original vision. In 2012, 
as part of the London Declaration on Neglected Tropical 
Diseases, Johnson & Johnson and GlaxoSmithKline 
together pledged 600 million doses of deworming 
drugs per year, enough to treat all school-age children at 
risk.4 This pledge was followed by major commitments 
by other donors in April, 2014, and the creation of a new 
global STH coalition.5 The intent of the coalition is not 
only to facilitate scale-up of drug coverage, but also, by 
engaging a broad network of multisectoral partners, to 
achieve a lasting eﬀ ect on STH-related morbidity, and, 
where possible, on transmission.6 
Reported coverage of preventive chemotherapy 
for at-risk school-age children was 39% in 2013,7 still 
below the 2020 target of 75% set by WHO.8 However, 
29 countries have already achieved the WHO target.7 
Should they set their sights higher and pursue the more 
ambitious goal of interrupting transmission? If so, 
what investments will result in the greatest likelihood 
of success? In which of these countries is transmission 
interruption most readily achievable? 
Brooker and colleagues oﬀ er a comprehensive 
framework and a robust analysis to inform the debate 
around these important questions. They identiﬁ ed ten 
key indicators that could be expected, on theoretical 
and practical grounds, to contribute to the likelihood 
of interrupting transmission. They considered not only 
factors related to parasite biology, such as transmission 
intensity and sanitation, but also indicators of 
programme capacity, such as logistics, infrastructure, 
governance, ﬁ nancial resources, and strength of the 
health and education systems. Such a broad perspective 
is especially relevant for STH, since drug delivery relies 
on existing platforms, such as schools, vitamin A 
supplementation, and other neglected tropical disease 
programmes. 
Which of the ten indicators identiﬁ ed by Brooker 
and colleagues are most crucial? The investigators 
compared four diﬀ erent weighting methods and, using 
a composite score, ranked countries into quintiles 
according to feasibility of interrupting transmission. 
Not surprisingly, high-feasibility countries had low 
transmission intensity, less environmental exposure 
to STH (ie, improved water and sanitation), and 
more highly functioning systems. Some readers will 
undoubtedly quibble with the ranking of speciﬁ c 
countries, but the investigators’ detailed presentation 
of their methods and assumptions invites us all into 
conversation and to action.
The STH community has rightly focused on scaling 
up preventive chemotherapy in areas of highest 
transmission and greatest need. However, countries 
vary tremendously in their capacity. For some, reaching 
75% drug coverage in school-age children by 2020 will 
represent a monumental achievement. There are many 
others for which interrupting transmission is not only 
possible, but feasible. Brooker and colleagues identiﬁ ed 
41 such countries. They also excluded from the analysis 
57 more potentially endemic countries, small island-
states, and countries undergoing rapid economic 
development. Many of these countries have pockets of 
ongoing transmission that, with improved monitoring 
and targeted interventions, could inform eventual 
end-game strategies for countries where transmission 
interruption is currently less feasible. Little is known 
about what combinations of WASH and drug coverage 
Soil-transmitted helminthiasis: back to the original point 
Da
vi
d 
Sc
ha
rf/
Sc
ie
nc
e 
Ph
ot
o 
Li
br
ar
y
Published Online
April 15, 2015
http://dx.doi.org/10.1016/
S1473-3099(15)70095-2
See Articles page 941
Comment
872 www.thelancet.com/infection   Vol 15   August 2015
3 WHO. Fifty-fourth World Health Assembly. WHA54.19. Schistosomiasis 
and soil-transmitted helminth infections. May, 22, 2001. http://apps.who.
int/gb/archive/pdf_ﬁ les/WHA54/ea54r19.pdf (accessed March 23, 2015).
4 Uniting to Combat Neglected Tropical Diseases. London Declaration on 
Neglected Tropical Diseases. http://www.who.int/neglected_diseases/
London_Declaration_NTDs.pdf (accessed Feb 22, 2015). 
5 Uniting to Combat Neglected Tropical Diseases. Delivering on promises and 
driving progress: the second report on uniting to combat NTDs. http://
unitingtocombatntds.org/report/delivering-promises-driving-progress-
second-report-uniting-combat-ntds (accessed Feb 22, 2015).
6 STH Coalition. Partners are uniting to stop the worms. http://www.
childrenwithoutworms.org/sth-coalition. (accessed Feb 22, 2015).
7 WHO. Soil-transmitted helminthiases: number of children treated in 2013. 
Wkly Epidemiol Rec 2015; 90: 89–94. 
8 WHO. Soil-transmitted helminthiases: eliminating soil-transmitted 
helminthiases as a public health problem in children: progress report 
2001–2010 and strategic plan 2011–2020. Geneva: World Health 
Organization, 2012.
9 Anderson RM, Truscott JE, Pullan RL, Brooker SJ, Hollingsworth TD. How 
eﬀ ective is school-based deworming for the community-wide control of 
soil-transmitted helminths? PLoS Negl Trop Dis 2013; 7: e2092.
10 Truscott J, Hollingsworth TD, Anderson R. Modeling the interruption of the 
transmission of soil-transmitted helminths by repeated mass 
chemotherapy of school-age children. PLoS Negl Trop Dis 2014; 8: e3323. 
11 Strunz EC, Addiss DG, Stocks M, Ogden S, Utzinger J, Freeman MC. Water, 
sanitation, hygiene and soil-transmitted helminth infection: a systematic 
review and meta-analysis. PLoS Med 2014; 11: e1001620. 
12 Anderson R, Truscott J, Hollingsworth TD. The coverage and frequency of 
mass drug administration required to eliminate persistent transmission of 
soil-transmitted helminths. Philos Trans R Soc Lond B Biol Sci 2014; 
369: 20130435. 
across diﬀ erent risk groups will be needed in various 
settings.9–12 It would be wise for the STH community 
to invest in learning from such situations now. By 
establishing appropriately ambitious STH targets in 
speciﬁ c settings, we will mobilise resources, reveal what 
is possible, clarify strategies, and strengthen our resolve. 
To paraphrase Lao Tzu, by being far reaching, we return 
to the original point of the WHA vision for STH control. 
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Maki ng mandatory vaccination truly compulsory: well 
intentioned but ill conceived
The USA, Australia, and about half of European countries 
have mandatory vaccination requirements.1,2 The 
experience of the USA and Australia has been well studied. 
In the USA, vaccine mandates are imple mented through 
requirements for proof of vaccination or exemption 
at school entry. In Australia, many provinces have 
school entry requirements and nationally mandated 
vaccination has traditionally been implemented by denial 
of childcare beneﬁ ts to those who refuse vaccines—
unless they provide proof of exemptions. Both countries 
have historically oﬀ ered non-medical exemptions to 
their compulsory laws to accommodate the minority of 
parents who object to vaccination. Studies3–5 have shown 
increased ease of granting non-medical exemptions to 
be associated with higher rates of refusal and pertussis. 
Therefore administrative requirements for exemptions 
might reduce rates of vaccine refusal.
Amid substantial media attention surrounding a 
measles outbreak that originated in Disneyland (Anaheim, 
CA, USA), well intentioned legislators in several states, 
have proposed legislation to get rid of non-medical 
exemptions, which would make mandatory vaccination 
truly compulsory. California removed all non-medical 
exemptions on June 18, 2015. In Vermont in 2012, after a 
contentious debate about elimination of the philosophical 
exemption, individuals opposed to compulsory vac-
cination formed a well organised coalition. Rather than 
eliminate the philosophical exemption, restrictions 
were added to both religious and philosophical non-
medical exemptions. In 2015, the debate resurfaced after 
legislation to eliminate the philosophical exemption 
was introduced. With strong support from the medical 
and public health community, Vermont abolished the 
philosophical exemption on May 28, 2015. Similarly, 
Australia eliminated a non-medical exemption to a vaccine 
requirement for childcare beneﬁ ts. Australians now 
must either vaccinate their children or forgo substantial 
childcare and family tax beneﬁ ts.6 This change introduces 
ﬁ nancial penalties for refusal, in a context in which many 
families cannot aﬀ ord childcare without these beneﬁ ts.7
These legislators are well intentioned. They see more 
parents worried about the safety of vaccines and that 
